Floatation-REST, EFT, and IFT for Anorexia
Trial Summary
What is the purpose of this trial?
The proposed study utilizes a randomized experimental therapeutics design to test a mechanistic framework linking interoceptive processing and disturbed body image, with the purpose of informing the development of future therapies for body image dissatisfaction in anorexia nervosa (AN). A sample of 102 participants will be recruited from the Laureate Eating Disorder Program (LEDP). After being randomized, participants will all receive a one-hour session of acceptance- and mindfulness-based training with a therapist (the introduction session). They will then receive either the interoceptively focused treatment (IFT) or exteroceptively focused treatment (EFT) condition based on randomization. In the IFT condition participants will engage in floatation-REST (Reduced Environmental Stimulation Therapy) while practicing acceptance and mindfulness-based principles. The EFT condition is an exteroceptive intervention in which participants will be asked to view pre-recorded videos of acceptance and mindfulness-based skills to aid in the practice of these skills. Each condition will consist of one introduction session and three experimental sessions. All participants will then return for follow-up measures. Assessed outcomes will include acute changes in body image disturbance (BID) and interoception. Further, longitudinal intervention effects on self-reported eating disorder symptoms, body image dissatisfaction, and interoception; behavioral measures of interoception and body image dissatisfaction; and resting state and interoceptive functioning during functional magnetic resonance imaging (fMRI) will be explored.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot start any new psychiatric medications in the week before randomization.
What data supports the effectiveness of the treatment Floatation-REST, EFT, and IFT for Anorexia?
Is Floatation-REST safe for humans?
Research suggests that Floatation-REST is generally safe for humans, as studies have shown no adverse events and no evidence of orthostatic hypotension (a drop in blood pressure when standing up) in participants with anorexia nervosa. It also appears to reduce anxiety and blood pressure while improving body image and awareness of internal sensations.12567
How does the treatment Floatation-REST differ from other treatments for anorexia nervosa?
Floatation-REST is unique because it involves sensory deprivation, which reduces sensory input to the brain, potentially lowering anxiety and improving body image and interoception (awareness of internal body sensations) in people with anorexia nervosa. Unlike traditional treatments that focus on nutrition and behavior, this therapy offers a non-pharmacological approach to address psychological symptoms.12356
Research Team
Emily M Choquette, PhD
Principal Investigator
Laureate Institute for Brain Research
Eligibility Criteria
This trial is for individuals aged 15-40 with a primary diagnosis of anorexia nervosa, BMI >18.5, transitioning from acute to residential care. They must not have started new psychiatric meds within the last week and should exhibit body image dissatisfaction as indicated by specific scale scores.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Introduction Session
Participants receive a one-hour session of acceptance- and mindfulness-based training with a therapist
Treatment
Participants receive either interoceptively focused treatment (IFT) or exteroceptively focused treatment (EFT) consisting of three sessions
Follow-up
Participants are monitored for changes in body image disturbance and interoception
Treatment Details
Interventions
- EFT (Behavioural Intervention)
- Floatation-REST (Behavioural Intervention)
- IFT (Behavioural Intervention)
Floatation-REST is already approved in Canada for the following indications:
- Chronic pain
- Fibromyalgia
- Post-traumatic stress disorder (PTSD)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Laureate Institute for Brain Research, Inc.
Lead Sponsor